Srs Capital Advisors, Inc. Blueprint Medicines Corp Transaction History
Srs Capital Advisors, Inc.
- $1.48 Billion
- Q1 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 117 shares of BPMC stock, worth $11,857. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117
Previous 50
134.0%
Holding current value
$11,857
Previous $4,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BPMC
# of Institutions
391Shares Held
68.5MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$674 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$673 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$549 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$390 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$311 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.05B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...